Back to 
Picton Mahoney Asset Management
Picton Mahoney Asset Management
MDGL
Showing 0 of 2 quarters
Position history for Picton Mahoney Asset Management's holdings in Madrigal Pharmaceuticals, Inc.
No. Picton Mahoney Asset Management exited its MDGL position in Q4 2022. Its Q3 2022 13F listed 11,215 shares worth $728,000. Picton Mahoney Asset Management first reported MDGL in Q3 2022 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.